Atlanta, GA—Biofisica Inc., an Atlanta-based company specializing in wound care therapy, has obtained a commitment of $2.3 million in financing from investors. The funding will support Biofisica’s continued marketing efforts in the UK and ongoing planning initiatives in the United States.

The round was led by Unilever Technology Ventures, Novartis Venture Funds, the ATDC Seed Capital Fund, as well as a number of private investors.

The company raised an $11 million A round and in 2007 obtained a $2 million debt financing from Leader Ventures.

Biofisica Inc., an Atlanta-based company specializing in wound care therapy, today announced that it has obtained a commitment of $2.3 million in financing from investors. The funding will support Biofisica’s continued marketing efforts in the UK and ongoing planning initiatives in the U.S.

The round was led by Unilever Technology Ventures, Novartis Venture Funds, the ATDC Seed Capital Fund, as well as a number of private investors.

“We believe that Biofisica’s POSiFECT technology represents an innovative and effective approach to the treatment of chronic wounds,” said Dion Madsen, managing director of Physic Ventures, the General Partner for Unilever Technology Ventures. “Chronic wounds are currently poorly treated and this technology approach represents a very convenient and cost effective therapy that has the potential to improve the lives of millions of chronic wound care patients.”

http://www.techjournalsouth.com/news/article.html?item_id=5197